Resource Library
Overview
Publications
Overview
Brochures
Factsheets
Milestones News
White Papers
Posters and Data Sheets
Case Studies
Editorials
NEW
Events
News
Archive
In The Media
Knowledge Hub
Brand Tools
Site Map
HOME
SERVICES
Discovery Services
Aptuit INDiGO™
API Development and Manufacture
Solid State Chemistry
Preclinical and Clinical Technologies
Pharmaceutical Sciences
Physical and Analytical Chemistry
Informatics
Consulting
Project Management
Aptuit Laurus
ABOUT US
Aptuit Vision
Executive Committee
Quality
History and Milestones
Aptuit Locations
Careers
Charitable Donations
RESOURCE LIBRARY
Publications
Events
News
Archive
In The Media
Knowledge Hub
Brand Tools
CONTACT US
SECURE ZONE
For sales and service enquiries call us now on
+1 816 767 3900
+44 131 451 2451
email us at
info@aptuit.com
For all other enquiries
please contact one of our global facilities
A
A
A
Publications
Milestones News
Milestones Winter 2009/10
The financial and productivity challenges facing the pharmaceutical industry call for a shift away from the traditional, fully-integrated pharmaceutical company toward collaborations that have mutual and measurable benefits for each party.
Milestones Fall 2009
In today’s challenging drug development environment, biopharmaceutical companies are seeking new paradigms to help them develop innovative therapies that are both time efficient and cost effective.
Milestones Summer 2009
Innovation is a word used liberally in the biotechnology and pharmaceutical sectors, yet we are seeing a new variation on the notion of innovation given both the current global economic pressures and the evolving needs of the industry and those we serve.
Milestones Winter 2008/9
This edition of Aptuit’s Milestones Newsletter explores the role of the qualified person in clinical trials in the EU, electronic solutions and submission, experimental screening methods to address polymorphism, and provides update on Aptuit’s joint venture in India, Aptuit Laurus.
Milestones Fall 2008
In this fourth edition of Aptuit's Milestones newsletter, Stephen Byrn, Ph.D., addresses the challenges associated with FDA’s Critical Path Initiative and Eyal Barash describes the patent implications of new chemical entities and amorphous states. Technologies, facilities, and expertise within Aptuit's business units are also explored.
Milestones Summer 2008
In this third edition of Milestones read about the art of working with a VC backed company and Kunal Khattar, Executive Director, Aptuit Laurus, explores the current state of the Indian marketplace and partnering with a CRO in this emerging market.
Home
|
Contact
|
About Us
|
Resource Library
|
Legal
|
Privacy
|
Site Map
© 2010 Aptuit Inc. All Rights Reserved.